|
Matt Fenske
Vice President, Lifecycle & Portfolio Strategy
Harmony Biosciences
|
Matt is currently the Vice President, Lifecycle & Portfolio Strategy at Harmony Biosciences. He responsibilities include advancing new products and lifecycle programs in the company portfolio as well as building the pipeline through business development. Prior to Harmony, Matt led the New Products Group at Shire for the Immunology and Hematology Franchises and also a similar role at Baxalta prior to that. Baxalta was a spin-off from Baxter where he held numerous roles in Global Marketing and US Marketing in the BioScience Business Unit. Matt also spent time with Boston Scientific (Guidant) in sales and marketing roles.